BARTOLUCCI, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 18.447
EU - Europa 11.746
AS - Asia 8.737
SA - Sud America 1.139
Continente sconosciuto - Info sul continente non disponibili 444
AF - Africa 240
OC - Oceania 135
Totale 40.888
Nazione #
US - Stati Uniti d'America 18.112
RU - Federazione Russa 3.703
IT - Italia 3.099
SG - Singapore 2.500
CN - Cina 2.151
PL - Polonia 1.320
HK - Hong Kong 1.248
BR - Brasile 882
VN - Vietnam 786
IE - Irlanda 773
KR - Corea 719
SE - Svezia 674
DE - Germania 494
FR - Francia 387
FI - Finlandia 363
IN - India 323
GB - Regno Unito 265
BD - Bangladesh 232
CA - Canada 216
ID - Indonesia 135
JP - Giappone 130
AU - Australia 128
UA - Ucraina 127
NL - Olanda 121
JO - Giordania 114
AR - Argentina 97
TR - Turchia 93
CH - Svizzera 92
ES - Italia 86
BE - Belgio 59
ZA - Sudafrica 57
MX - Messico 54
DK - Danimarca 49
EC - Ecuador 43
IQ - Iraq 42
CO - Colombia 36
CI - Costa d'Avorio 34
NG - Nigeria 33
PK - Pakistan 28
VE - Venezuela 25
PH - Filippine 23
TW - Taiwan 23
UZ - Uzbekistan 23
CL - Cile 21
SA - Arabia Saudita 21
EG - Egitto 20
LT - Lituania 19
MA - Marocco 18
CZ - Repubblica Ceca 16
KE - Kenya 16
RO - Romania 16
IL - Israele 15
MY - Malesia 15
NP - Nepal 15
AT - Austria 14
DZ - Algeria 14
PY - Paraguay 14
TH - Thailandia 14
CR - Costa Rica 12
AL - Albania 11
AE - Emirati Arabi Uniti 10
PT - Portogallo 10
BJ - Benin 9
HN - Honduras 9
BG - Bulgaria 8
KG - Kirghizistan 8
KZ - Kazakistan 8
TN - Tunisia 8
IR - Iran 7
NZ - Nuova Zelanda 7
PE - Perù 7
QA - Qatar 7
SC - Seychelles 7
SN - Senegal 7
AZ - Azerbaigian 6
BB - Barbados 6
BH - Bahrain 6
BO - Bolivia 6
HU - Ungheria 6
JM - Giamaica 6
LB - Libano 6
LV - Lettonia 6
NI - Nicaragua 6
RS - Serbia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
NO - Norvegia 5
MM - Myanmar 4
MO - Macao, regione amministrativa speciale della Cina 4
OM - Oman 4
EE - Estonia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 40.398
Città #
Santa Clara 3.621
Ashburn 2.367
Singapore 1.859
Warsaw 1.312
Fairfield 1.215
Hong Kong 1.061
Chandler 822
Dublin 764
San Jose 733
Seoul 672
Woodbridge 601
Seattle 538
Houston 515
Hefei 493
Cambridge 476
Florence 450
Milan 427
Wilmington 404
Beijing 393
Council Bluffs 376
Los Angeles 332
Ann Arbor 296
Ho Chi Minh City 270
Munich 268
Rome 248
The Dalles 244
Dallas 231
Buffalo 217
Lawrence 213
Altamura 210
Princeton 194
Lauterbourg 192
Jacksonville 189
Helsinki 174
Hanoi 172
New York 162
Moscow 160
Mumbai 135
Boardman 134
Boston 132
Tokyo 118
Melbourne 112
Shanghai 97
Medford 94
Kent 93
San Diego 87
Paris 84
Jakarta 81
Clifton 75
São Paulo 75
Chicago 72
Bern 70
Bologna 65
Turku 64
London 62
Naples 60
Orem 56
Turin 53
Toronto 48
Redondo Beach 47
San Francisco 45
Brussels 44
Montreal 44
Phoenix 44
Figino 42
Lappeenranta 42
Atlanta 41
Guangzhou 40
Pune 39
Bengaluru 38
Frankfurt am Main 37
Porto Alegre 36
Brooklyn 35
Abidjan 34
Denver 34
Chennai 32
Johannesburg 32
Abuja 31
Izmir 31
Gavirate 30
Haiphong 29
Hillsboro 29
Salt Lake City 29
Barcelona 28
Da Nang 28
Dong Ket 26
Miano 25
Norwalk 25
Genoa 23
Hangzhou 23
Bari 22
Falls Church 22
Redwood City 22
Verona 22
Belo Horizonte 21
Copenhagen 21
Tashkent 21
Rio de Janeiro 20
Amsterdam 19
Brasília 19
Totale 26.010
Nome #
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 744
Oleuropein-rich leaf extract affects intestinal microbiota and free fatty acids in Apc-mutant and wt rats 424
Gonadotropin-releasing hormone modulates cholesterol synthesis and steroidogenesis in SH-SY5Y cells. 405
Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap. 383
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 344
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression 331
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 325
CHINESE ASTRAGALUS ROOT EXTRACTS: A CASE STUDY 322
New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators 308
Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method. 291
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 283
QUANTITATIVE ANALYSIS OF LACTOYLGLUTATHIONE: A NEW 2D-HPLC-MS/MS APPROACH WITHOUT ION-PAIR AGENTS 280
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers 275
Isotopic dilution GC-MS measurement of 4-Hydroxyandrostendione in postmenopausal breast cancer 274
Evaluation and comparison of short chain fatty acids composition in gut diseases 274
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced anti-proliferative profiles. 267
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 266
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 258
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 256
Metformin reacts directly with glucose following the Maillard reaction pathway 253
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 251
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 250
2-Butyl-4-oxo-3-([2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl)-3-aza-1-azoniaspiro[4.4]non-1-ene chloride 1.69-hydrate (irbesartan hydrochloride 1.69-hydrate) 246
Gut microbiota metabolites mediate the interplay between childhood maltreatment and psychopathology in patients with eating disorders 245
Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry 244
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 243
Similar but Different: The Case of Metoprolol Tartrate and Succinate Salts 238
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 238
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 232
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 231
Development of a method for the quantification of estrone and estradiol in serum by LC-MS/MS 231
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 230
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 227
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 227
Corso di formazione specialistica. L'accoppiamento cromatografia liquida ad alte prestazioni-spettrometria di massa (HPLC-MS): principi e applicazioni 222
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 219
A CONVENIENT ROUTE TO THE SYNTHESIS OF ISOTOPOMERIC DIHYDRO-2(3H)FURANONES 216
Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors 216
Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine 215
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 214
Energy resolved tandem mass spectrometry experiments for resolution of isobaric compounds: a case of cis/trans isomerism 214
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 213
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 211
Diisopropyl[2-[2-(2-oxopyrrolidin-1-yl)acetamido]ethyl]ammonium hydrogen sulfate 210
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 209
Disodium 2,2'-dithiobis(ethanesulfonate) trihydrate (dimesna trihydrate) 208
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 207
Development of a HPLC-MS/MS method for the pharmacokinetic studies of Pirfenidone in pig plasma 207
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 205
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 204
Vitamin D3 quantification in a cod liver oil-based supplement 203
4-Amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide 203
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 203
Effect of ancient wheat pasta on gut microbiota composition and bacteria-derived metabolites: A randomized controlled trial 201
3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl 4-aminobenzoate 201
Antarctic bacteria as producers of antibiotic volatile compounds inhibiting cystic fibrosis pathogens 200
Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria 199
Aminoarylesters as multidrug resistance (MDR) reverting agents endowed with high potency and efficacy 199
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 199
A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance 198
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 197
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 197
Monitoring of air-dispersed formaldehyde and carbonyl compounds as vapors and adsorbed on particulate matter by denuder-filter sampling and gas chromatographic analysis 197
Combining liquid chromatography and tandem mass spectrometry approaches to the study of monoterpene glycosides (Aroma precursors) in wine grape 197
Effects of Ultramicronized N-Palmitoylethanolamine Supplementation on Tramadol and Oxycodone Analgesia and Tolerance Prevention 197
Vaginal lactobacilli and vaginal dysbiosis-associated bacteria differently affect cervical epithelial and immune homeostasis and anti-viral defenses 196
GC-MS Volatolomic Approach to Study the Antimicrobial Activity of the Antarctic Bacterium Pseudoalteromonas sp. TB41 195
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 195
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII 195
Liquid chromatography tandem mass spectrometric quantitation of sulfamethazine and its metabolites: direct analysis of swine urine by triple quadrupole and by ion trap mass spectrometry. 195
Aromatic sulfonamides including a sulfonic acid tail: New membrane impermeant carbonic anhydrase inhibitors for targeting selectively the cancer‐associated isoforms 194
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 193
Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut–Retina Axis in Patients with Neovascular Age-Related Macular Degeneration—A Randomized Clinical Trial 192
Bioactive volatile organic compounds from Antarctic (sponges) bacteria 191
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 189
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 187
In Vitro Evidence for the Use of Astragali Radix Extracts as Adjuvant against Oxaliplatin-Induced Neurotoxicity 187
Changes in faecal microbiota profile and plasma biomarkers following the administration of an antioxidant oleuropein-rich leaf extract in a rat model mimicking colorectal cancer 186
ERMS EXPERIMENTS FOR RESOLUTION OF ISOBARIC COMPOUNDS: A CASE OF CIS/TRANS ISOMERISM 186
Selective determination of aloin in different matrices by HPTLC densitometry in fluorescence mode 185
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers 184
Sample Preparation for Direct MS Analysis of Food 184
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents 184
Oli essenziali: analisi e caratterizzazione mediante GC-MS e GC-MS/MS 184
2- or 3-Substituted piperazines as nootropic agents: carbethoxy and hydroxymethyl analogues of the cognition-enhancer DM235 183
New dual P-Glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as Multidrug Resistance (MDR) reversers in cancer cells 182
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 180
Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease 180
Antarctic sponge bacteria: a new potential source of natural antibiotic compounds 180
SERS detection of benzophenones on viologen functionalized Ag nanoparticles: application to breakfast cereals 180
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases 180
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 179
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 179
Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis 179
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 179
Development and validation of a quantitative spectrophotometric method to detect the amount of carbon monoxide in treated tuna fish. 178
Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm 176
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 176
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 176
Thermalisation in CID MS/MS on a QqQ: towards ion trap CID excitation conditions ? 175
Totale 22.741
Categoria #
all - tutte 114.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.276 0 118 122 49 24 53 110 87 57 62 251 343
2022/20233.665 321 711 207 233 270 601 438 213 365 36 134 136
2023/20241.699 66 154 225 95 128 223 68 296 59 103 141 141
2024/202511.455 367 1.067 702 1.604 2.937 1.570 372 633 679 335 609 580
2025/202614.806 1.500 1.747 1.204 1.260 1.543 605 1.739 710 947 908 542 2.101
2026/20271.031 710 321 0 0 0 0 0 0 0 0 0 0
Totale 40.888